ImmunityBio Inc. Common Stock vs iShares US Aerospace & Defense ETF — how do they compare? ImmunityBio Inc. Common Stock trades at $10.37 (market cap $10.51B), while iShares US Aerospace & Defense ETF trades at $205.65 (market cap $11.87B). The key difference: ImmunityBio Inc. Common Stock and iShares US Aerospace & Defense ETF are close in size by market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, iShares US Aerospace & Defense ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and iShares US Aerospace & Defense ETF for 18 Days on average.
| IBRX | ITA | |
|---|---|---|
Market Cap | $10.51B | $11.87B |
Volume | 10,445,785 | 1,060,125 |
Sector | Health | Sector/Thematic |
52-Week High | $11.55 | $253.22 |
52-Week Low | $1.98 | $198.23 |
Typical Hold Time | 0 Days | 18 Days |
Enterprise Value | $10.97B | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →iShares U.S. Aerospace & Defense ETF seeks to track U.S. companies in the aerospace and defense sector. Its holdings include manufacturers of commercial and military aircraft, defense systems, and related equipment.
Read more on ITA →